South Jersey Drug Treatment Center
South Jersey Drug Treatment Center: Financial Volatility Amidst Consistent Leadership
EIN: 222221530 · Bridgeton, NJ · Updated: 2026-04-04
| Metric | Value |
|---|---|
| Total Revenue | $817K |
| Total Expenses | $790K |
| Program Spending | 75% |
| CEO/Top Officer Pay | $500,000 |
| Net Assets | $11K |
| Transparency Score | 65/100 |
Is South Jersey Drug Treatment Center Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
South Jersey Drug Treatment Center directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About South Jersey Drug Treatment Center
South Jersey Drug Treatment Center (EIN: 222221530) is a nonprofit organization based in Bridgeton, NJ. The organization reported total revenue of $817K and total assets of $45K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of South Jersey Drug Treatment Center's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
South Jersey Drug Treatment Center is a small nonprofit that has been operating for 35 years, with 14 years of IRS 990 filings on record (2011–2024). Revenue has grown at a compound annual rate of 4.1%.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
| Total Revenue | $768K |
| Total Expenses | $790K |
| Surplus / Deficit | $-21,550 |
| Total Assets | $24K |
| Total Liabilities | $12K |
| Net Assets | $11K |
| Operating Margin | -2.8% |
| Debt-to-Asset Ratio | 51.8% |
| Months of Reserves | 0.4 months |
Financial Health Grade: D
In 2024, South Jersey Drug Treatment Center reported a deficit of $22K with expenses exceeding revenue, holds 0.4 months of operating reserves (limited), has a debt-to-asset ratio of 51.8% (high leverage).
Financial Trends
Over 14 years of filings (2011–2024), South Jersey Drug Treatment Center's revenue has grown at a compound annual growth rate (CAGR) of 4.1%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2024 | +13.0% | +24.1% | -47.8% |
| 2023 | +23.5% | +19.1% | +761.3% |
| 2022 | -6.5% | -21.7% | — |
| 2021 | -6.5% | +0.0% | -100.6% |
| 2020 | -11.1% | -3.1% | +44.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1991 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates South Jersey Drug Treatment Center with a Mission Score of 65 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, South Jersey Drug Treatment Center allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $22K, with expenses exceeding revenue.
- Debt-to-asset ratio: 51.8%.
Executive Compensation Analysis
Executive compensation is reported as 'c0%' across all available filings, which is highly unusual for an organization with revenues exceeding $500,000 annually and warrants further investigation into how leadership is compensated.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of South Jersey Drug Treatment Center's IRS 990 filings:
- Consistent reporting of 'c0%' for compensation raises concerns about transparency regarding executive salaries.
- Negative assets reported in 2021 ($ -415) indicate a period of severe financial distress.
- Significant year-over-year fluctuations in revenue and expenses suggest potential instability in funding or program delivery.
Strengths
The following positive indicators were identified for South Jersey Drug Treatment Center:
- The organization has maintained operations for at least seven years despite financial volatility, demonstrating resilience.
- Liabilities have been consistently low and stable, indicating responsible debt management.
- The organization has managed to recover from periods of negative assets, showing an ability to adapt and survive.
Frequently Asked Questions about South Jersey Drug Treatment Center
Is South Jersey Drug Treatment Center a legitimate charity?
Based on AI analysis of IRS 990 filings, South Jersey Drug Treatment Center (EIN: 222221530) some concerns. Mission Score: 65/100. 3 red flags identified, 3 strengths noted.
How does South Jersey Drug Treatment Center spend its money?
South Jersey Drug Treatment Center directs 75% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to South Jersey Drug Treatment Center tax-deductible?
South Jersey Drug Treatment Center is registered as a tax-exempt nonprofit (EIN: 222221530). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the South Jersey Drug Treatment Center CEO make?
South Jersey Drug Treatment Center's highest-compensated officer earns $500,000 annually. The organization reported $817K in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of South Jersey Drug Treatment Center's spending goes to programs?
South Jersey Drug Treatment Center directs 75% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is South Jersey Drug Treatment Center located?
South Jersey Drug Treatment Center is headquartered in Bridgeton, New Jersey and files with the IRS under EIN 222221530.
How many years of IRS 990 filings does South Jersey Drug Treatment Center have?
South Jersey Drug Treatment Center has 14 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $817K in total revenue.
What does South Jersey Drug Treatment Center do?
South Jersey Drug Treatment Center is a nonprofit organization in the Unknown sector, located in Bridgeton, New Jersey. It is classified under NTEE code Unknown.
How much revenue does South Jersey Drug Treatment Center have?
South Jersey Drug Treatment Center reported total revenue of $816,752. Based on 14 IRS 990 filings on record.
What are South Jersey Drug Treatment Center's total assets?
South Jersey Drug Treatment Center holds total assets of $44,924 as reported in IRS 990 filings.
Where is South Jersey Drug Treatment Center located?
South Jersey Drug Treatment Center is based in Bridgeton, New Jersey.
What is South Jersey Drug Treatment Center's EIN?
South Jersey Drug Treatment Center's Employer Identification Number (EIN) is 222221530. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is South Jersey Drug Treatment Center?
South Jersey Drug Treatment Center is classified under NTEE code Unknown (Unknown).
Is South Jersey Drug Treatment Center a registered 501(c)(3)?
South Jersey Drug Treatment Center appears in IRS records (EIN: 222221530). Check the IRS Tax Exempt Organization Search for the most current determination letter status.
Does South Jersey Drug Treatment Center file IRS Form 990?
Yes, South Jersey Drug Treatment Center has 14 IRS Form 990 filings on record. The most recent covers tax period 202406.
What was South Jersey Drug Treatment Center's revenue in 2024?
In the 202406 filing period, South Jersey Drug Treatment Center reported total revenue of $768,238, total expenses of $789,788, and net assets of $23,531.
Is South Jersey Drug Treatment Center's revenue growing or declining?
South Jersey Drug Treatment Center's revenue is growing. Revenue went from $679,815 (202306) to $768,238 (202406), a +13.0% change. Based on 14 filings on record.
What is South Jersey Drug Treatment Center's most recent 990 filing?
The most recent IRS Form 990 filing for South Jersey Drug Treatment Center covers tax period 202406. It shows revenue of $768,238, expenses of $789,788, total assets of $23,531, and liabilities of $12,200.
How much does South Jersey Drug Treatment Center spend on programs vs administration?
Based on IRS 990 analysis, South Jersey Drug Treatment Center allocates approximately 75% of expenses to program services, 15% to administrative costs, and 10% to fundraising. This indicates strong program focus.
Is South Jersey Drug Treatment Center a trustworthy charity?
Based on AI analysis of IRS 990 data, South Jersey Drug Treatment Center shows mixed signals. Mission Score: 65/100 (Good). 3 red flags identified. 3 strengths noted.
What are the red flags for South Jersey Drug Treatment Center?
The following concerns were identified: Consistent reporting of 'c0%' for compensation raises concerns about transparency regarding executive salaries.. Negative assets reported in 2021 ($ -415) indicate a period of severe financial distress.. Significant year-over-year fluctuations in revenue and expenses suggest potential instability in funding or program delivery.. These flags are based on automated analysis of IRS 990 public filings and should be verified independently.
What are South Jersey Drug Treatment Center's strengths?
Positive indicators for South Jersey Drug Treatment Center include: The organization has maintained operations for at least seven years despite financial volatility, demonstrating resilience.. Liabilities have been consistently low and stable, indicating responsible debt management.. The organization has managed to recover from periods of negative assets, showing an ability to adapt and survive.. These findings are derived from AI analysis of the organization's financial filings.
How does South Jersey Drug Treatment Center compensate executives?
Executive compensation is reported as 'c0%' across all available filings, which is highly unusual for an organization with revenues exceeding $500,000 annually and warrants further investigation into how leadership is compensated. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
Given the 'c0%' compensation reporting, how does the organization attract and retain qualified leadership and staff, and what is the actual compensation structure for key personnel?
The consistent reporting of 'c0%' for compensation across all filings is highly unusual and suggests that executive compensation is either entirely pro-bono, or it is being reported in a manner that does not clearly disclose actual salaries, potentially through a related entity or as part of other expense categories. This lack of transparency makes it difficult to assess the fairness and competitiveness of leadership compensation.
What factors contributed to the significant swings in revenue and expenses, particularly the negative assets in 2021, and what measures have been implemented to stabilize financial performance?
The data shows substantial revenue fluctuations (e.g., $708,159 in 2019 to $588,826 in 2021) and a concerning instance of negative assets in 2021 ($ -415). This volatility could be due to inconsistent grant funding, changes in service demand, or operational inefficiencies. Without more detailed financial statements, it's difficult to pinpoint exact causes or assess the effectiveness of any stabilization strategies.
Filing History
IRS 990 filing history for South Jersey Drug Treatment Center showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2011–2024), South Jersey Drug Treatment Center's revenue has grown by 69.4%, moving from $453K to $768K. Total assets increased by 26.6% over the same period, from $19K to $24K. Total functional expenses rose by 73.1%, from $456K to $790K. In its most recent filing year (2024), South Jersey Drug Treatment Center reported a deficit of $22K, with expenses exceeding revenue. The organization holds $12K in liabilities against $24K in assets (debt-to-asset ratio: 51.8%), resulting in net assets of $11K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2024 | $768K | $790K | $24K | $12K | — | View 990 |
| 2023 | $680K | $636K | $45K | $12K | — | — |
| 2022 | $550K | $534K | $5K | $12K | — | View 990 |
| 2021 | $589K | $682K | $-415 | $12K | — | — |
| 2020 | $630K | $682K | $70K | $93K | — | View 990 |
| 2019 | $708K | $704K | $49K | $16K | — | View 990 |
| 2018 | $616K | $631K | $44K | $16K | — | — |
| 2017 | $510K | $470K | $60K | $16K | — | View 990 |
| 2016 | $490K | $502K | $28K | $24K | — | View 990 |
| 2015 | $492K | $494K | $26K | $12K | — | View 990 |
| 2014 | $512K | $509K | $39K | $22K | — | View 990 |
| 2013 | $510K | $501K | $28K | $13K | — | View 990 |
| 2012 | $481K | $484K | $18K | $29K | — | View 990 |
| 2011 | $453K | $456K | $19K | $27K | — | View 990 |
Year-by-Year Financial Summary
- 2024: Revenue of $768K, expenses of $790K, and assets of $24K (revenue +13.0% year-over-year).
- 2023: Revenue of $680K, expenses of $636K, and assets of $45K (revenue +23.5% year-over-year).
- 2022: Revenue of $550K, expenses of $534K, and assets of $5K (revenue -6.5% year-over-year).
- 2021: Revenue of $589K, expenses of $682K, and assets of $-415 (revenue -6.5% year-over-year).
- 2020: Revenue of $630K, expenses of $682K, and assets of $70K (revenue -11.1% year-over-year).
- 2019: Revenue of $708K, expenses of $704K, and assets of $49K (revenue +15.0% year-over-year).
- 2018: Revenue of $616K, expenses of $631K, and assets of $44K (revenue +20.6% year-over-year).
- 2017: Revenue of $510K, expenses of $470K, and assets of $60K (revenue +4.1% year-over-year).
- 2016: Revenue of $490K, expenses of $502K, and assets of $28K (revenue -0.3% year-over-year).
- 2015: Revenue of $492K, expenses of $494K, and assets of $26K (revenue -3.8% year-over-year).
- 2014: Revenue of $512K, expenses of $509K, and assets of $39K (revenue +0.4% year-over-year).
- 2013: Revenue of $510K, expenses of $501K, and assets of $28K (revenue +5.9% year-over-year).
- 2012: Revenue of $481K, expenses of $484K, and assets of $18K (revenue +6.2% year-over-year).
- 2011: Revenue of $453K, expenses of $456K, and assets of $19K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for South Jersey Drug Treatment Center:
Data Sources and Methodology
This transparency report for South Jersey Drug Treatment Center is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.